Symposium - Philadelphia, Pennsylvania
The Targeting Parkinson’s Disease symposium will address both disease modification and therapeutic development for levodopa induced dyskinesia, an unmet medical need within Parkinson’s treatment, and other PD-treatment symptoms. Advances in target identification, biomarker development, and genetics (such as LRKK2 and alpha-synuclein) will also be discussed
(Photo courtesy of Loews Philadelphia Hotel)
Link to Organization web page http://www.worldpharmacongress.com/prk/
Monday, June 4, 2012 (8:00 a.m. - 6: 00 p.m.)
Loews Philadelphia Hotel, Philadelphia, Pennsylvania
Contact: Nilufer Donmez (ndonmez@healthtech.com)
Phone: 781-247-6257
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
